Abstract
Tumor suppressor protein deleted in liver cancer 1 (DLC1) is a RhoGTPase-activating protein (RhoGAP) and inhibits cancer cell migration by inactivating downstream target protein RhoA. A few studies have reported the regulations of reactive oxygen species (ROS) on RhoGAP. In this study, we investigated flavone (the core structure of flavonoids)-induced regulation on ROS generation and DLC1/RhoA pathway in MCF-7 and MDA-MB-231 breast cancer cells and explored whether flavone-induced upregulation of DLC1 is mediated by ROS. Our results showed that flavone decreased ROS production and inhibited cell migration through DLC1/RhoA pathway. To further investigate the role of ROS in flavone-induced regulation on DLC1/RhoA pathway, hydrogen peroxide was added to restore the ROS levels. Flavone-induced upregulation of DLC1 expression, downregulation of RhoA activity, and inhibition of cell migration were all restrained by hydrogen peroxide. We also found that flavone increased DLC1 stability by inhibiting DLC1 protein degradation in breast cancer cells. In summary, our study demonstrated that flavone inhibited cell migration through DLC1/RhoA pathway by decreasing ROS generation and suppressed DLC1 degradation in MCF-7 and MDA-MB-231 breast cancer cells.
Similar content being viewed by others
References
Aghajanian A, Wittchen ES, Campbell SL, Burridge K (2009) Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 4:e8045
Baek I, Jeon SB, Song MJ, Yang E, Sohn UD, Kim IK (2009) Flavone attenuates vascular contractions by inhibiting RhoA/Rho kinase pathway. Korean J Physiol Pharmacol 13:201–207
Barrera G (2012) Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012:137289
Barras D, Widmann C (2014) GAP-independent functions of DLC1 in metastasis. Cancer Metastasis Rev 33:87–100
Braun AC, Olayioye MA (2015) Rho regulation: DLC proteins in space and time. Cell Signal 27:1643–1651
Fujita M, Imadome K, Shoji Y, Isozaki T, Endo S, Yamada S, Imai T (2015) Carbon-ion irradiation suppresses migration and invasiveness of human pancreatic carcinoma cells MIAPaCa-2 via Rac1 and RhoA degradation. Int J Radiat Oncol Biol Phys 93:173–180
Ghosh CC, Mukherjee A, David S, Milam KE, Hunter JT, Parikh SM (2015) Angiopoietin-1 requires oxidant signaling through p47phox to promote endothelial barrier defense. PLoS One 10:e0119577
Gibson SB (2010) A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy 6:835–837
Holeiter G, Heering J, Erlmann P, Schmid S, Jähne R, Olayioye MA (2008) Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res 68:8743–8751
Kang KA, Piao MJ, Kim KC, Cha JW, Zheng J, Yao CW, Chae S, Hyun JW (2014) Fisetin attenuates hydrogen peroxide-induced cell damage by scavenging reactive oxygen species and activating protective functions of cellular glutathione system. In Vitro Cell Dev Biol Anim 50:66–74
Kesarwani P, Murali AK, Al-Khami AA, Mehrotra S (2013) Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 18:1497–1534
Kim TY, Lee JW, Kim HP, Jong HS, Kim TY, Jung M, Bang YJ (2007) DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun 355:72–77
Kim TY, Vigil D, Der CJ, Juliano RL (2009) Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev 28:77–83
Kim TY, Jackson S, Xiong Y, Whitsett TG, Lobello JR, Weiss GJ, Tran NL, Bang YJ, Der CJ (2013) CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth. Proc Natl Acad Sci U S A 110:16868–16873
Lanciano P, Khalfaoui-Hassani B, Selamoglu N, Ghelli A, Rugolo M, Daldal F (2013) Molecular mechanisms of superoxide production by complex III: a bacterial versus human mitochondrial comparative case study. Biochim Biophys Acta 1827:1332–1339
Li G, Du X, Vass WC, Papageorge AG, Lowy DR, Qian X (2011) Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci U S A 108:17129–17134
Li QF, Spinelli AM, Tang DD (2009) Cdc42GAP, reactive oxygen species, and the vimentin network. Am J Physiol Cell Physiol 297:C299–309
Li QF, Tang DD (2009) Role of p47(phox) in regulating Cdc42GAP, vimentin, and contraction in smooth muscle cells. Am J Physiol Cell Physiol 297:C1424–1433
Li TS, Marbán E (2010) Physiological levels of reactive oxygen species are required to maintain genomic stability in stem cells. Stem Cells 28:1178–1185
Liu L, Luo Y, Chen L, Shen T, Xu B, Chen W, Zhou H, Han X, Huang S (2010) Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem 285:38362–38373
Lopez-Haber C, Kazanietz MG (2013) Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1. Mol Pharmacol 83:1141–1154
Luo HW, Luo QP, Yuan Y, Zhu XY, Huang SF, Peng Z, Li CL, Huang ZG, Feng WL (2011) The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B. Biochem Biophys Res Commun 404:279–283
Ma L, Zhu WZ, Liu TT, Fu HL, Liu ZJ, Yang BW, Song TY, Li GR (2015) H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells. Asian Pac J Cancer Prev 16:1637–1642
Meng XG, Yue SW (2014) Dexamethasone disrupts cytoskeleton organization and migration of T47D human breast cancer cells by modulating the AKT/mTOR/RhoA pathway. Asian Pac J Cancer Prev 15:10245–10250
Meng Y, Li T, Zhou GS, Chen Y, Yu CH, Pang MX, Li W, Li Y, Zhang WY, Li X (2015) The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway. Antioxid Redox Signal 22:241–258
Mukherjee D, Sen A, Aguilar RC (2014) RhoGTPase-binding proteins, the exocyst complex and polarized vesicle trafficking. Small GTPases 5, e28453
Ni J, Dong Z, Han W, Kondrikov D, Su Y (2013) The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis. Free Radic Biol Med 61:26–39
Nimnual AS, Taylor LJ, Bar-Sagi D (2003) Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5:236–241
O'Connor K, Chen M (2013) Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4:141–147
Popescu NC, Goodison S (2014) Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther 18:293–302
Reczek CR, Chandel NS (2015) ROS-dependent signal transduction. Curr Opin Cell Biol 33:8–13
Taverne YJ, Bogers AJ, Duncker DJ, Merkus D (2013) Reactive oxygen species and the cardiovascular system. Oxid Med Cell Longev 2013:862423
Tsai IT, Yang ZS, Lin ZY, Wen CC, Cheng CC, Chen YH (2012) Flavone is efficient to protect zebrafish fins from UV-induced damage. Drug Chem Toxicol 35:341–346
Ullmannova V, Popescu NC (2007) Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev 31:110–118
Urao N, Ushio-Fukai M (2013) Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med 54:26–39
Valdameri G, Kenski JC, Moure VR, Trombetta-Lima M, Martinez GR, Sogayar MC, Winnischofer SM, Rocha ME (2014) Flavone induces cell death in human hepatoma HepG2 cells. Nat Prod Commun 9:1457–60
Wang J, Sun L, Yang M, Luo W, Gao Y, Liu Z, Qiu X, Wang E (2013) DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer. J Histochem Cytochem 61:510–521
Wenzel U, Kuntz S, Brendel MD, Daniel H (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60:3823–3831
Wenzel U, Nickel A, Daniel H (2005) Increased mitochondrial palmitoylcarnitine/carnitine countertransport by flavone causes oxidative stress and apoptosis in colon cancer cells. Cell Mol Life Sci 62:3100–3105
Wong CM, Wei L, Au SL, Fan DN, Zhou Y, Tsang FH, Law CT, Lee JM, He X, Shi J, Wong CC, Ng IO (2015) MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget 6:13658–13670
Zhang H, Liu X, Liu Y, Yi B, Yu X (2011) Epithelial-mesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway. In Vitro Cell Dev Biol Anim 47:165–172
Zhao R, Liu K, Huang Z, Wang J, Pan Y, Huang Y, Deng X, Liu J, Qin C, Cheng G, Hua L, Li J, Yin C (2015) Genetic variants in caveolin-1 and RhoA/ROCK1 are associated with clear cell renal cell carcinoma risk in a Chinese population. PLoS One 10:e0128771
Zhu W, Yang B, Fu H, Ma L, Liu T, Chai R, Zheng Z, Zhang Q, Li G (2015) Flavone inhibits nitric oxide synthase (NOS) activity, nitric oxide production and protein S-nitrosylation in breast cancer cells. Biochem Biophys Res Commun 458:590–595
Acknowledgments
This work was supported by the special funds of the National Natural Science Foundation of China (Grant No. 31340035), the Major Key Science and Technology Project of Shandong Province (2015ZDJS04003), the Science and Technology Development Program of Shandong Province (2012CSF12112), the Key Program of Shandong Provincial Natural Science Foundation (ZR2013CZ002), the Research Fund for the Doctoral Program of Higher Education of China (20113704110004), and the Science and Technology Program of Jinan (201202033).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Zhu, W., Ma, L., Yang, B. et al. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells. In Vitro Cell.Dev.Biol.-Animal 52, 589–597 (2016). https://doi.org/10.1007/s11626-016-0010-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-016-0010-8